SNPs associated with follicular lymphoma survival from phase 1 of the analysis (P ≤ 0.15 from the codominant model)
Gene . | SNP . | P value* . | Deleterious genotype(s)† . | HR . | 95% CI . |
---|---|---|---|---|---|
FCGR2A | rs1801274 | .04 | GG | 1.63 | 0.90-2.94 |
IL1RN | rs454078 | .03 | AA | 1.93 | 1.11-3.34 |
IL2 | rs2069762 | .01 | GT/TT | 1.80 | 1.06-3.05 |
IL3 | rs40401 | .13 | CC/CT | 1.28 | 0.77-2.13 |
IL5 | rs2069818 | .005 | AC/AA | 5.58 | 1.66-18.6 |
IL8 | rs4073 | .06 | TT | 2.14 | 1.26-3.63 |
IL8 | rs2227307 | .11 | TT | 1.90 | 1.12-3.22 |
IL8 | rs2227306 | .07 | CC | 1.96 | 1.07-3.28 |
IL8RB | rs1126580 | .07 | AA | 1.64 | 0.97-2.79 |
IL12B | rs3212227 | .0009 | AC/CC | 1.83 | 1.09-3.06 |
IL13 | rs1800925 | .03 | CT/TT | 1.56 | 0.92-2.66 |
IL16 | rs11325 | .07 | CT/TT | 1.61 | 0.96-2.70 |
TNF | rs361525 | .15 | AG/AA | 1.77 | 0.86-3.64 |
TNF | rs1799724 | .09 | CC | 1.39 | 0.68-2.86 |
Gene . | SNP . | P value* . | Deleterious genotype(s)† . | HR . | 95% CI . |
---|---|---|---|---|---|
FCGR2A | rs1801274 | .04 | GG | 1.63 | 0.90-2.94 |
IL1RN | rs454078 | .03 | AA | 1.93 | 1.11-3.34 |
IL2 | rs2069762 | .01 | GT/TT | 1.80 | 1.06-3.05 |
IL3 | rs40401 | .13 | CC/CT | 1.28 | 0.77-2.13 |
IL5 | rs2069818 | .005 | AC/AA | 5.58 | 1.66-18.6 |
IL8 | rs4073 | .06 | TT | 2.14 | 1.26-3.63 |
IL8 | rs2227307 | .11 | TT | 1.90 | 1.12-3.22 |
IL8 | rs2227306 | .07 | CC | 1.96 | 1.07-3.28 |
IL8RB | rs1126580 | .07 | AA | 1.64 | 0.97-2.79 |
IL12B | rs3212227 | .0009 | AC/CC | 1.83 | 1.09-3.06 |
IL13 | rs1800925 | .03 | CT/TT | 1.56 | 0.92-2.66 |
IL16 | rs11325 | .07 | CT/TT | 1.61 | 0.96-2.70 |
TNF | rs361525 | .15 | AG/AA | 1.77 | 0.86-3.64 |
TNF | rs1799724 | .09 | CC | 1.39 | 0.68-2.86 |